Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)-Reference-Cited by-同舟云学术

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

Published:1999-09 Issue:9 Volume:35 Page:1338-1342
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Maindrault-Goebel F,Louvet C,André T,Carola E,Lotz J.P,Molitor J.L,Garcia M.L,Gilles-Amar V,Izrael V,Krulik M,de Gramont A

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference17 articles.

1. Oxaliplatin: mechanism of action and antineoplastic activity;Raymond;Semin. Oncol.,1998

2. Two consecutive phase II studies of oxaliplatin for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines;Machover;Ann. Oncol.,1996

3. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump;Lévi;Cancer,1992

4. A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen;de Gramont;Eur. J. Cancer,1998

5. Oxaliplatin with high-dose folinic acid and 5-fluorouracil 48 h infusion in pretreated metastatic colorectal cancer;de Gramont;Proc. Am. Soc. Clin. Oncol.,1994

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment;Frontiers in Immunology;2023-09-18

2. Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies;Frontiers in Pharmacology;2023-08-01

3. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study;Journal of Clinical Oncology;2023-07-01

4. PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway;International Journal of Molecular Sciences;2023-06-11

5. Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer;Cancers;2023-04-12